JANUX THERAPEUTICS INC (JANX)
US47103J1051 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -60.54M | -58.29M | -63.06M | -32.67M | -6.78M | |||
| Depreciation Amortization | 2.08M | 1.96M | 840.00K | 110.00K | 10.00K | |||
| Change In Working Capital | -64.00K | -6.55M | 4.28M | 8.84M | 2.12M | |||
| Other non cash items | 21.53M | 12.32M | 15.02M | 6.74M | 280.00K | |||
| OPERATING CASH FLOW | -36.99M | -50.58M | -42.92M | -16.98M | -4.37M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -827.00K | -1.85M | -6.45M | -1.48M | 0.00 | |||
| Other Investing Activity | -279.99M | -39.34M | 64.71M | -339.48M | N/A | |||
| INVESTING CASH FLOW | -280.82M | -41.19M | 58.27M | -340.96M | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 2.50M | |||
| Stock Issued/Repurchased | 327.41M | 59.55M | 500.00K | 182.36M | 9.02M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 204.17M | 0.00 | |||
| FINANCING CASH FLOW | 327.41M | 59.55M | 500.00K | 386.52M | 11.52M | |||
| CHANGE IN CASH | 9.60M | -32.22M | 15.85M | 28.58M | 7.15M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -36.99M | -50.58M | -42.92M | -16.98M | -4.37M | |||
| Capital Expenditure | -827.00K | -1.85M | -6.45M | -1.48M | 0.00 | |||
| FREE CASH FLOW | -37.82M | -52.43M | -49.37M | -18.46M | -4.37M | |||
All data in USD